TANYA LUMBANGAOL: Open Payments
NPI 1972018513 · FONTANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$779 in 38 payments from 6 companies in 2025. Trend: 2023 $110 · 2024 $1,001 · 2025 $779
Food & beverage: $779
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 32 | $554 |
| Novo Nordisk Inc | 1 | $125 |
| Boston Scientific Corporation | 2 | $34 |
| Tonix Medicines, Inc. | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| SCILEX PHARMACEUTICALS INC. | 1 | $20 |
Products named: RELISTOR, Ozempic, TONMYA, XTAMPZA, WaveWriter Alpha Prime 16, ZTLido, General - Therapies.
Industry payments across CA — which companies pay providers there.
